Relative Age Effect in Attention Deficit/Hyperactivity Disorder at Various Stages of the Medicalization Process.
Attention Deficit/Hyperactivity Disorder (ADHD)
children
medicalization
parents
relative age effect
teachers
Journal
Children (Basel, Switzerland)
ISSN: 2227-9067
Titre abrégé: Children (Basel)
Pays: Switzerland
ID NLM: 101648936
Informations de publication
Date de publication:
15 Jun 2022
15 Jun 2022
Historique:
received:
13
04
2022
revised:
16
05
2022
accepted:
09
06
2022
entrez:
24
6
2022
pubmed:
25
6
2022
medline:
25
6
2022
Statut:
epublish
Résumé
Diagnosis and pharmacological treatment of ADHD are more common among the youngest children in a classroom, born in the months immediately preceding the school entry cutoff date. The mechanisms behind this phenomenon, called the relative age effect (RAE), are not yet well understood. Nearly all hypotheses involve the school system, various teachers' actions, and concern children's immaturity. However, most previous studies have been based on reports of health professionals' diagnoses and prescriptions found in official databases rather than on reports of teachers' behavior identification or suspicion of ADHD, despite their being at the first stages of the medicalization process. Our study overcomes this limitation by using reports of parents' and teachers' behavior identification or suspicion of ADHD within a three-level multilevel survey design, comprising 1294 children, 130 teachers, and 17 elementary public schools. The goal of our study was to investigate whether RAE stems (1) from adults' judgement of the child's expression of immaturity or (2) from the consequences associated with the child's double burden of being immature and exhibiting ADHD behaviors. Our multilevel analyses put forward the first hypothesis only, supporting the medicalization of immaturity. RAE in ADHD seems mostly initiated by teachers' pre-diagnostic actions toward younger children.
Identifiants
pubmed: 35740826
pii: children9060889
doi: 10.3390/children9060889
pmc: PMC9221667
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Social Sciences and Humanities Research Council of Canada
ID : 430-2017-00926
Organisme : Fonds de recherche Québécois sur la société et la culture
ID : 2018-NP-204941
Références
BMJ Evid Based Med. 2018 Feb;23(1):1-3
pubmed: 29367314
Med Clin (Barc). 2015 Dec 7;145(11):471-6
pubmed: 25913908
Complement Ther Med. 2020 Mar;49:102352
pubmed: 32147074
Health (London). 2004 Jan;8(1):61-80
pubmed: 15018718
J Am Acad Child Adolesc Psychiatry. 2022 Feb;61(2):291-297
pubmed: 34389201
Child Psychiatry Hum Dev. 2016 Jun;47(3):440-58
pubmed: 26266467
J Child Psychol Psychiatry. 2019 Apr;60(4):392-394
pubmed: 30919477
Eur Child Adolesc Psychiatry. 2021 Jun 5;:
pubmed: 34089381
Ann Clin Psychiatry. 2011 Feb;23(1):25-9
pubmed: 21318193
Eur Neuropsychopharmacol. 2017 May;27(5):484-493
pubmed: 28336088
Ann Fam Med. 2003 Sep-Oct;1(3):171-4
pubmed: 15043379
Child Adolesc Psychiatry Ment Health. 2017 Jan 17;11:5
pubmed: 28105068
J Child Psychol Psychiatry. 2014 Nov;55(11):1244-50
pubmed: 24813478
Front Sociol. 2022 May 30;7:814763
pubmed: 35707639
Eur Child Adolesc Psychiatry. 2019 Nov;28(11):1417-1429
pubmed: 30293121
PLoS Med. 2006 Apr;3(4):e182
pubmed: 16597177
Neurotherapeutics. 2012 Jul;9(3):490-9
pubmed: 22976615
CMAJ. 2012 Apr 17;184(7):755-62
pubmed: 22392937
Int J Qual Stud Health Well-being. 2017 Jun;12(sup1):1298267
pubmed: 28532329
J Health Econ. 2010 Sep;29(5):641-56
pubmed: 20638739
Pharmacoepidemiol Drug Saf. 2016 Jun;25(6):652-60
pubmed: 26823045
Can J Psychiatry. 2012 Feb;57(2):93-101
pubmed: 22340149
J Child Psychol Psychiatry. 2014 Aug;55(8):897-904
pubmed: 24673585
J Child Psychol Psychiatry. 2019 Apr;60(4):380-391
pubmed: 30317644
J Am Acad Child Adolesc Psychiatry. 2020 Aug;59(8):990-997
pubmed: 31442562
Lancet Psychiatry. 2017 Nov;4(11):868-875
pubmed: 29033006
J Pediatr. 2016 May;172:162-167.e1
pubmed: 26973148